MediWound (MDWD) EBITDA Margin (2014 - 2025)
MediWound (MDWD) recorded quarterly EBITDA Margin of 384.84% in Q4 2025, down 685.16% quarter-over-quarter from 49.01% in Q3 2025, and down 31799.0% on a YoY basis from N/an in Q4 2024.
MediWound (MDWD) EBITDA Margin (2014 - 2025) Analysis & Trends
MediWound's EBITDA Margin history runs 12 years deep, the most recent figure standing at 384.84% for Q4 2025.
- In Q4 2025, EBITDA Margin fell 31799.0% year-over-year to 384.84%; the TTM figure through Dec 2025 stood at 18.23% (up 11260.0% YoY), while the FY2025 annual figure was 140.93%, up 850.0% from the prior year.
- EBITDA Margin was 384.84% for Q4 2025 at MediWound, down from 49.01% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 344.06% in Q2 2025 to a low of 384.84% in Q4 2025.
- Historically, EBITDA Margin has averaged 73.5% across 5 years, with a median of 78.52% in 2021.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin soared 29326 bps in 2024, then tumbled 31799 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 75.71% in 2021, then increased by 15 bps to 64.36% in 2022, then surged by 49 bps to 32.86% in 2023, then plunged by 103 bps to 66.85% in 2024, then tumbled by 476 bps to 384.84% in 2025.
- The last three EBITDA Margin figures came in at 384.84% (Q4 2025), 49.01% (Q3 2025), and 344.06% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -384.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -384.84% |
| Sep 30, 2025 | -49.01% |
| Jun 30, 2025 | 344.06% |
| Mar 31, 2025 | -18.33% |
| Dec 31, 2024 | -66.85% |
| Sep 30, 2024 | -236.26% |
| Jun 30, 2024 | 179.88% |
| Mar 31, 2024 | -195.83% |
| Dec 31, 2023 | -32.86% |
| Sep 30, 2023 | -45.83% |
| Jun 30, 2023 | -113.38% |
| Mar 31, 2023 | -97.45% |
| Dec 31, 2022 | -64.36% |
| Sep 30, 2022 | -72.15% |
| Jun 30, 2022 | -156.18% |
| Mar 31, 2022 | -81.33% |
| Dec 31, 2021 | -75.71% |
| Sep 30, 2021 | -101.24% |
| Jun 30, 2021 | -105.79% |
| Mar 31, 2021 | -96.60% |